What AI says about Applied Therapeutics

Applied Therapeutics is a biopharmaceutical company developing govorestat, an investigational therapy for rare diseases including Classical Galactosemia and CMT-SORD. The company has discontinued its sponsored clinical studies of govorestat to evaluate new development strategies after the FDA issued a Complete Response Letter for the drug in November 2024.